Experienced clinical team focus on high potential targets
Obtain future market-leading drugs
through in-house R&D or licensed in assets
Global Clinical Operation
Department of Clinical Research
Department of Medicine
Department of Registration
Reasonable and efficient trial planning
Forward-looking design & parallel actions: start the next phase of the process based on anticipation to reduce the total duration
Envafolimab from Phase I to NDA only takes less than 4 years
70+ cooperative hospitals
20+ covered provinces
82+ renowned PIs